Skip to content
20-F

Annual Report (Foreign)

Jyong Biotech Ltd. MENS

0001213900-26-057073

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 73.01M sh
Shares Diluted FY 2025 · Dec 31, 2024 71.57M sh
Shares Diluted FY 2025 · Dec 31, 2023 71.57M sh
Shares Outstanding FY 2025 · Dec 31, 2025 76.03M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$3.04M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$3.62M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$2.6M
Long Term Debt FY 2025 · Dec 31, 2025 $2.12M
Short Term Debt FY 2025 · Dec 31, 2025 $15.34M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.18M
Cash And Equivalents FY 2025 · Dec 31, 2024 $101K
Cash And Equivalents FY 2025 · Dec 31, 2023 $1.74M
Cash And Equivalents FY 2025 · Dec 31, 2022 $2.27M
Stockholders Equity FY 2025 · Dec 31, 2025 −$24.91M
Stockholders Equity FY 2025 · Dec 31, 2024 −$36.52M
Stockholders Equity FY 2025 · Dec 31, 2023 −$34.07M
Stockholders Equity FY 2025 · Dec 31, 2022 −$29.63M
Current Liabilities FY 2025 · Dec 31, 2025 $34.81M
Current Liabilities FY 2025 · Dec 31, 2024 $12.13M
Total Liabilities FY 2025 · Dec 31, 2025 $45.68M
Total Liabilities FY 2025 · Dec 31, 2024 $42.89M
Current Assets FY 2025 · Dec 31, 2025 $15.54M
Current Assets FY 2025 · Dec 31, 2024 $206K
Total Assets FY 2025 · Dec 31, 2025 $20.78M
Total Assets FY 2025 · Dec 31, 2024 $6.37M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.06
Eps Diluted FY 2025 · Dec 31, 2024 −$0.04
Eps Diluted FY 2025 · Dec 31, 2023 −$0.06
Eps Basic FY 2025 · Dec 31, 2025 −$0.06
Eps Basic FY 2025 · Dec 31, 2024 −$0.04
Eps Basic FY 2025 · Dec 31, 2023 −$0.06
Sga Expense FY 2025 · Dec 31, 2025 $1.75M
Sga Expense FY 2025 · Dec 31, 2024 $1.09M
Sga Expense FY 2025 · Dec 31, 2023 $1.68M
Rd Expense FY 2025 · Dec 31, 2025 $813K
Rd Expense FY 2025 · Dec 31, 2024 $927K
Rd Expense FY 2025 · Dec 31, 2023 $1.07M
Net Income FY 2025 · Dec 31, 2025 −$4.67M
Net Income FY 2025 · Dec 31, 2024 −$3.02M
Net Income FY 2025 · Dec 31, 2023 −$4.4M
Operating Income FY 2025 · Dec 31, 2025 −$2.61M
Operating Income FY 2025 · Dec 31, 2024 −$2.06M
Operating Income FY 2025 · Dec 31, 2023 −$2.8M
Stock Repurchased FY 2025 · Nov 15, 2022 $16.37M
Stock Repurchased FY 2025 · Nov 15, 2022 ¥112.5M
Stock Repurchased FY 2025 · May 31, 2019 $16.37M
Stock Repurchased FY 2025 · May 31, 2019 ¥112.5M